- Home
- FSV vs RGEN Comparison
FSV vs RGEN Comparison
Compare FSV & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSV
- RGEN
- Stock Information
- Founded
- FSV 1988
- RGEN 1981
- Country
- FSV Canada
- RGEN United States
- Employees
- FSV N/A
- RGEN N/A
- Industry
- FSV Real Estate
- RGEN Medical/Dental Instruments
- Sector
- FSV Finance
- RGEN Health Care
- Exchange
- FSV Nasdaq
- RGEN Nasdaq
- Market Cap
- FSV N/A
- RGEN 9.0B
- IPO Year
- FSV N/A
- RGEN N/A
- Fundamental
- Price
- FSV $165.98
- RGEN $127.24
- Analyst Decision
- FSV Buy
- RGEN Buy
- Analyst Count
- FSV 5
- RGEN 12
- Target Price
- FSV $201.00
- RGEN $177.78
- AVG Volume (30 Days)
- FSV 183.1K
- RGEN 716.8K
- Earning Date
- FSV 04-24-2025
- RGEN 04-30-2025
- Dividend Yield
- FSV 0.66%
- RGEN N/A
- EPS Growth
- FSV 32.59
- RGEN N/A
- EPS
- FSV 2.97
- RGEN N/A
- Revenue
- FSV $5,216,894,000.00
- RGEN $634,439,000.00
- Revenue This Year
- FSV $8.82
- RGEN $12.02
- Revenue Next Year
- FSV $6.32
- RGEN $14.99
- P/E Ratio
- FSV $55.88
- RGEN N/A
- Revenue Growth
- FSV 20.36
- RGEN 0.33
- 52 Week Low
- FSV $141.26
- RGEN $113.50
- 52 Week High
- FSV $197.84
- RGEN $184.98
- Technical
- Relative Strength Index (RSI)
- FSV 39.64
- RGEN 33.21
- Support Level
- FSV $165.99
- RGEN $135.71
- Resistance Level
- FSV $174.59
- RGEN $147.00
- Average True Range (ATR)
- FSV 4.70
- RGEN 6.40
- MACD
- FSV 0.11
- RGEN -1.48
- Stochastic Oscillator
- FSV 43.65
- RGEN 6.49
Stock Price Comparison Chart: FSV vs RGEN
About RGEN Repligen Corporation
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.